ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This "Early Metabolic Look" Strategy?

Komal Jhaveri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.